362 related articles for article (PubMed ID: 9466562)
1. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
Takeda A; Mallory M; Sundsmo M; Honer W; Hansen L; Masliah E
Am J Pathol; 1998 Feb; 152(2):367-72. PubMed ID: 9466562
[TBL] [Abstract][Full Text] [Related]
2. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E
Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
[TBL] [Abstract][Full Text] [Related]
3. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.
Wakabayashi K; Matsumoto K; Takayama K; Yoshimoto M; Takahashi H
Neurosci Lett; 1997 Dec; 239(1):45-8. PubMed ID: 9547168
[TBL] [Abstract][Full Text] [Related]
4. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
5. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
[TBL] [Abstract][Full Text] [Related]
6. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.
Masliah E; Iwai A; Mallory M; Uéda K; Saitoh T
Am J Pathol; 1996 Jan; 148(1):201-10. PubMed ID: 8546207
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
[TBL] [Abstract][Full Text] [Related]
8. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
9. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
Iwai A
Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.
Wakabayashi K; Hayashi S; Kakita A; Yamada M; Toyoshima Y; Yoshimoto M; Takahashi H
Acta Neuropathol; 1998 Nov; 96(5):445-52. PubMed ID: 9829807
[TBL] [Abstract][Full Text] [Related]
11. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
13. NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains.
Wakabayashi K; Hayashi S; Yoshimoto M; Kudo H; Takahashi H
Acta Neuropathol; 2000 Jan; 99(1):14-20. PubMed ID: 10651022
[TBL] [Abstract][Full Text] [Related]
14. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
15. Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies.
Wakabayashi K; Yoshimoto M; Fukushima T; Koide R; Horikawa Y; Morita T; Takahashi H
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):363-8. PubMed ID: 10564525
[TBL] [Abstract][Full Text] [Related]
16. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Masliah E
Acta Neuropathol; 2000 Mar; 99(3):296-304. PubMed ID: 10663973
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
Dickson DW; Feany MB; Yen SH; Mattiace LA; Davies P
J Neural Transm Suppl; 1996; 47():31-46. PubMed ID: 8841955
[TBL] [Abstract][Full Text] [Related]
18. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.
Arima K; Uéda K; Sunohara N; Hirai S; Izumiyama Y; Tonozuka-Uehara H; Kawai M
Brain Res; 1998 Oct; 808(1):93-100. PubMed ID: 9795161
[TBL] [Abstract][Full Text] [Related]
19. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
Arawaka S; Saito Y; Murayama S; Mori H
Neurology; 1998 Sep; 51(3):887-9. PubMed ID: 9748051
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development.
Hsu LJ; Mallory M; Xia Y; Veinbergs I; Hashimoto M; Yoshimoto M; Thal LJ; Saitoh T; Masliah E
J Neurochem; 1998 Jul; 71(1):338-44. PubMed ID: 9648883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
